Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis

Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis

Although treatment of visceral leishmaniasis with pentavalent antimony is usually successful, some patients require second-line drug therapy, most commonly with amphotericin B. To identify the clinical characteristics that predict an inadequate response to pentavalent antimony, a case-control study...

Full description

Bibliographic Details
Main Authors: Santos Mácia A., Marques Raynério C., Farias Carolinne A., Vasconcelos Danielle M., Stewart Jay M., Costa Dorcas L., Costa Carlos H.N.
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2002-01-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Visceral leishmaniasis
Antimony
Amphotericin B
Therapy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822002000600014

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822002000600014

Similar Items